Knut Brockow
#162,621
Most Influential Person Now
Researcher
Knut Brockow's AcademicInfluence.com Rankings
Knut Brockowcomputer-science Degrees
Computer Science
#9479
World Rank
#9953
Historical Rank
Machine Learning
#4157
World Rank
#4206
Historical Rank
Artificial Intelligence
#4501
World Rank
#4563
Historical Rank
Database
#6444
World Rank
#6677
Historical Rank
Download Badge
Computer Science
Why Is Knut Brockow Influential?
(Suggest an Edit or Addition)Knut Brockow's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Anaphylaxis: guidelines from the European Academy of Allergy and Clinical Immunology (2014) (814)
- Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations (2003) (780)
- General considerations for skin test procedures in the diagnosis of drug hypersensitivity (2002) (731)
- International Consensus on drug allergy (2014) (711)
- Standards and standardization in mastocytosis: Consensus Statements on Diagnostics, Treatment Recommendations and Response Criteria (2007) (695)
- Skin test concentrations for systemically administered drugs – an ENDA/EAACI Drug Allergy Interest Group position paper (2013) (689)
- Diagnosis of immediate allergic reactions to beta‐lactam antibiotics (2003) (525)
- Definitions, Criteria and Global Classification of Mast Cell Disorders with Special Reference to Mast Cell Activation Syndromes: A Consensus Proposal (2011) (479)
- Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients (2008) (427)
- Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti‐inflammatory drugs (2013) (399)
- EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity (2007) (390)
- Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA * (2011) (375)
- Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice. (2011) (306)
- General considerations on rapid desensitization for drug hypersensitivity – a consensus statement (2010) (282)
- Management of hypersensitivity reactions to iodinated contrast media (2005) (268)
- Diagnosis of nonimmediate reactions to β‐lactam antibiotics (2004) (266)
- Cutaneous manifestations in patients with mastocytosis: Consensus report of the European Competence Network on Mastocytosis; the American Academy of Allergy, Asthma & Immunology; and the European Academy of Allergology and Clinical Immunology. (2016) (258)
- Skin testing in patients with hypersensitivity reactions to iodinated contrast media – a European multicenter study (2009) (228)
- Effects of tyrosine kinase inhibitor STI571 on human mast cells bearing wild-type or mutated c-kit. (2003) (211)
- Drug hypersensitivity in children: report from the pediatric task force of the EAACI Drug Allergy Interest Group (2016) (205)
- The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria (2021) (188)
- Guideline for acute therapy and management of anaphylaxis (2014) (184)
- Advances in the Classification and Treatment of Mastocytosis: Current Status and Outlook toward the Future. (2017) (181)
- Desensitization in delayed drug hypersensitivity reactions – an EAACI position paper of the Drug Allergy Interest Group (2013) (176)
- Using a gluten oral food challenge protocol to improve diagnosis of wheat-dependent exercise-induced anaphylaxis. (2015) (152)
- Efficacy of antihistamine pretreatment in the prevention of adverse reactions to Hymenoptera immunotherapy: a prospective, randomized, placebo-controlled trial. (1997) (152)
- Research needs in allergy: an EAACI position paper, in collaboration with EFA (2012) (151)
- In vitro tests for drug hypersensitivity reactions: an ENDA/EAACI Drug Allergy Interest Group position paper (2016) (144)
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis (2014) (144)
- Epidemiology, prognosis, and risk factors in mastocytosis. (2014) (139)
- Guideline for the diagnosis of drug hypersensitivity reactions (2015) (136)
- Towards a more precise diagnosis of hypersensitivity to beta‐lactams — an EAACI position paper (2019) (132)
- Wheat‐dependent exercise‐induced anaphylaxis (2016) (131)
- EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivity (2018) (123)
- Activation of human mast cells by aggregated IgG through FcgammaRI: additive effects of C3a. (2004) (123)
- Proposed Diagnostic Algorithm for Patients with Suspected Mast Cell Activation Syndrome. (2019) (118)
- International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis. (2013) (113)
- Long-term efficacy of medium-dose UVA1 phototherapy in atopic dermatitis. (2000) (97)
- Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels, and bone marrow pathology. (2003) (96)
- Perceived Food Allergy in Children in 10 European Nations (2007) (93)
- Vaccination and allergy: EAACI position paper, practical aspects (2017) (93)
- Effect of Gentian Violet, Corticosteroid and Tar Preparations in Staphylococcus-aureus-Colonized Atopic Eczema (1999) (92)
- Drug hypersensitivity in clonal mast cell disorders: ENDA/EAACI position paper (2015) (86)
- Practical Guidance for the Evaluation and Management of Drug Hypersensitivity: Specific Drugs. (2020) (85)
- The role of mobile health technologies in allergy care: An EAACI position paper (2019) (85)
- Anaphylaxis to radiographic contrast media (2011) (80)
- Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis (2015) (79)
- EAACI guidelines: Anaphylaxis (2021 update) (2021) (75)
- [Skin tests for diagnostics of allergic immediate-type reactions. Guideline of the German Society for Allergology and Clinical Immunology]. (2011) (74)
- Immediate and delayed reactions to radiocontrast media: is there an allergic mechanism? (2009) (70)
- IL-6 levels predict disease variant and extent of organ involvement in patients with mastocytosis. (2005) (69)
- Antihistamines in urticaria (1999) (69)
- Contrast media hypersensitivity--scope of the problem. (2005) (67)
- Controversies in Drug Allergy: Radiographic Contrast Media. (2019) (67)
- The therapeutic concept of “patient management” in atopic eczema (1996) (66)
- Why the 20% + 2 Tryptase Formula Is a Diagnostic Gold Standard for Severe Systemic Mast Cell Activation and Mast Cell Activation Syndrome (2019) (64)
- Drug allergy in mast cell disease (2012) (63)
- Increased postmortem serum mast cell tryptase in a fatal anaphylactoid reaction to nonionic radiocontrast medium. (1999) (63)
- Lysozyme in wine: A risk evaluation for consumers allergic to hen's egg. (2009) (62)
- History and classification of anaphylaxis. (2004) (62)
- Mastocytosis and Anaphylaxis. (2017) (61)
- Skin tests in the diagnosis of drug hypersensitivity reactions. (2008) (61)
- Mast cells as a unique hematopoietic lineage and cell system: From Paul Ehrlich's visions to precision medicine concepts (2020) (61)
- Hypersensitivity to contrast media and dyes. (2014) (60)
- Effect of acupuncture on allergen-induced basophil activation in patients with atopic eczema:a pilot trial. (2011) (59)
- Peripheral blood eosinophils and other non‐invasive biomarkers can monitor treatment response in eosinophilic oesophagitis (2015) (57)
- Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project (2009) (57)
- Hypersensitivity reactions to iodinated contrast media. (2006) (57)
- International prognostic scoring system for mastocytosis (IPSM): a retrospective cohort study. (2019) (57)
- Human mast cells express androgen receptors but treatment with testosterone exerts no influence on IgE‐independent mast cell degranulation elicited by neuromuscular blocking agents (2010) (55)
- Exercise Lowers Threshold and Increases Severity, but Wheat-Dependent, Exercise-Induced Anaphylaxis Can Be Elicited at Rest. (2018) (55)
- Wheat-Dependent Cofactor-Augmented Anaphylaxis: A Prospective Study of Exercise, Aspirin, and Alcohol Efficacy as Cofactors. (2019) (54)
- Dihydroxyacetone in a New Formulation – A Powerful Therapeutic Option in Vitiligo (2001) (51)
- Levels of mast-cell growth factors in plasma and in suction skin blister fluid in adults with mastocytosis: correlation with dermal mast-cell numbers and mast-cell tryptase. (2002) (51)
- Mast cell-derived proteases control allergic inflammation through cleavage of IgE. (2008) (51)
- Added sensitivity of component‐resolved diagnosis in hymenoptera venom‐allergic patients with elevated serum tryptase and/or mastocytosis (2016) (50)
- Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update (2021) (49)
- Drug allergy passport and other documentation for patients with drug hypersensitivity – An ENDA/EAACI Drug Allergy Interest Group Position Paper (2016) (49)
- Allergenicity of wine containing processing aids: a double-blind, placebo-controlled food challenge. (2009) (44)
- Hypersensitivity reactions to non‐betalactam antibiotics in children: An extensive review (2014) (44)
- Comparison of molecular and extract-based allergy diagnostics with multiplex and singleplex analysis (2015) (44)
- Immediate and delayed cutaneous reactions to radiocontrast media. (2012) (44)
- Anaphylactic reactions to local anesthetics. (2010) (43)
- Systemic treatments in the management of atopic dermatitis: A systematic review and meta‐analysis (2020) (43)
- H1-Antihistamine Up-Dosing in Chronic Spontaneous Urticaria: Patients' Perspective of Effectiveness and Side Effects – A Retrospective Survey Study (2011) (42)
- Allergies and COVID‐19 vaccines: An ENDA/EAACI Position paper (2022) (41)
- Anaphylaxis: acute treatment and management. (2010) (40)
- Radiocontrast Media Hypersensitivity: Skin Testing Differentiates Allergy From Nonallergic Reactions and Identifies a Safe Alternative as Proven by Intravenous Provocation. (2019) (40)
- Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal (2021) (39)
- A EAACI drug allergy interest group survey on how European allergy specialists deal with β‐lactam allergy (2019) (38)
- Adverse reactions to drugs and biologics in patients with clonal mast cell disorders: A Work Group Report of the Mast Cells Disorder Committee, American Academy of Allergy, Asthma & Immunology. (2019) (38)
- Rupatadine: efficacy and safety of a non-sedating antihistamine with PAF-antagonist effects (2014) (38)
- Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity (2020) (37)
- Guideline on diagnostic procedures for suspected hypersensitivity to beta-lactam antibiotics (2019) (37)
- Heterogeneity of molecular sensitization profiles in grass pollen allergy – implications for immunotherapy? (2014) (37)
- Late skin test reactions to radiocontrast medium. (1999) (36)
- Genetic variants associated with drugs‐induced immediate hypersensitivity reactions: a PRISMA‐compliant systematic review (2016) (35)
- Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)‐syndrome: a new entity within the spectrum of autoinflammatory syndromes? (2016) (34)
- Regression of urticaria pigmentosa in adult patients with systemic mastocytosis: correlation with clinical patterns of disease. (2002) (33)
- Adverse reactions to foods. (2001) (33)
- Diagnosing, managing and preventing anaphylaxis: Systematic review (2020) (33)
- For the European Network of Drug Allergy and the EAACI interest group on drug hypersensitivity. General considerations on rapid desensitization for drug hypersenitivity - a consensus statement (2010) (33)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria: A systematic review for the EAACI Biologicals Guidelines (2020) (32)
- Pathogenesis of drug allergy – current concepts and recent insights (2015) (32)
- European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives (2012) (32)
- Mastocytosis (2001) (31)
- Classification and pathophysiology of radiocontrast media hypersensitivity. (2010) (30)
- Diagnosis, Classification and Management of Mast Cell Activation Syndromes (MCAS) in the Era of Personalized Medicine (2020) (30)
- The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives. (2019) (30)
- Changes in collagen I and collagen III metabolism in patients with generalized atopic eczema undergoing medium‐dose ultraviolet A1 phototherapy (2000) (29)
- Development of a sensitive ELISA for the detection of casein-containing fining agents in red and white wines. (2014) (29)
- Cytochrome P450s in human immune cells regulate IL-22 and c-Kit via an AHR feedback loop (2017) (29)
- Allergen cleavage by effector cell‐derived proteases regulates allergic inflammation (2006) (29)
- Acanthosis Nigricans: A Marker for Hyperinsulinemia (1995) (28)
- An EAACI task force report: recognising the potential of the primary care physician in the diagnosis and management of drug hypersensitivity (2018) (28)
- Clinical Overview of Cutaneous Features in Hypereosinophilic Syndrome (2012) (28)
- Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification (2020) (27)
- Global Allergy Forum and Second Davos Declaration 2013 Allergy: Barriers to cure – challenges and actions to be taken (2014) (27)
- Experience with polyethylene glycol allergy‐guided risk management for COVID‐19 vaccine anaphylaxis (2021) (27)
- COVID-19 Vaccination in Mastocytosis: Recommendations of the European Competence Network on Mastocytosis (ECNM) and American Initiative in Mast Cell Diseases (AIM) (2021) (26)
- Managing a child with possible allergy to vaccine (2014) (26)
- Extensive blistering is a predictor for severe complications in children with mastocytosis (2012) (26)
- Update on Diagnosis and Treatment of Mastocytosis (2011) (25)
- Mast cell activation syndrome: Importance of consensus criteria and call for research. (2018) (24)
- Efficacy and safety of dupilumab for moderate‐to‐severe atopic dermatitis: A systematic review for the EAACI biologicals guidelines (2020) (24)
- Positive skin tests in late reactions to radiographic contrast media. (1999) (24)
- Effects of topical treatment with the raft modulator miltefosine and clobetasol in cutaneous mastocytosis: a randomized, double‐blind, placebo‐controlled trial (2010) (24)
- Intradermal Tests With Drugs: An Approach to Standardization (2020) (24)
- Allergological approach to drug hypersensitivity reactions (2008) (24)
- Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase? (2014) (23)
- Definition of an exercise intensity threshold in a challenge test to diagnose food‐dependent exercise‐induced anaphylaxis (2009) (23)
- Clinical presentation and diagnosis of meat allergy in Switzerland and Southern Germany. (2009) (22)
- Risk and management of patients with mastocytosis and MCAS in the SARS-CoV-2 (COVID-19) pandemic: Expert opinions (2020) (22)
- Failure of omalizumab and successful control with ketotifen in a patient with vibratory angio‐oedema (2013) (22)
- The Impact and Consequences of SARS-CoV-2 Pandemic on a Single University Dermatology Outpatient Clinic in Germany (2020) (22)
- Impact of wine manufacturing practice on the occurrence of fining agents with allergenic potential (2014) (21)
- Molecular Background, Clinical Features and Management of Pediatric Mastocytosis: Status 2021 (2021) (21)
- Adverse Drug Reactions: Mechanisms and Assessment (2002) (21)
- Serum Eosinophil Cationic Protein is Superior to Mast Cell Tryptase as Marker for Response to Topical Corticosteroid Therapy in Eosinophilic Esophagitis (2014) (21)
- Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry (2019) (21)
- Hydrolysed egg displays strong decrease in allergenicity and is well tolerated by egg‐allergic patients (2016) (20)
- Update of the S2k guideline on the management of IgE-mediated food allergies (2021) (20)
- Can Immunoglobulin E‐measurement replace challenge tests in allergic rhinoconjunctivits to grass pollen? (2011) (20)
- Low frequency of IgE-mediated food hypersensitivity in mastocytosis. (2020) (20)
- Component Resolved Diagnosis in Hymenoptera Anaphylaxis (2017) (20)
- Diagnosis and management of the drug hypersensitivity reactions in Coronavirus disease 19: An EAACI Position Paper (2020) (20)
- The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe (2005) (20)
- Exanthematous lichen planus in a child – response to acitretin (1997) (19)
- Optimizing the therapeutic approach in tinea capitis of childhood with itraconazole (2000) (19)
- Onychogryphosis in elderly persons: an indicator of long-standing poor nursing care? Report of one case and review of the literature. (2001) (19)
- Practical recommendations for the allergological risk assessment of the COVID-19 vaccination – a harmonized statement of allergy centers in Germany (2021) (19)
- Medical algorithm: Diagnosis and treatment of radiocontrast media hypersensitivity (2019) (19)
- Practical handling of allergic reactions to COVID-19 vaccines (2021) (19)
- The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD). (2010) (19)
- Cofactors of wheat-dependent exercise-induced anaphylaxis do not increase highly individual gliadin absorption in healthy volunteers (2019) (18)
- Adverse reactions during procedures: hypersensitivity to contrast agents and dyes. (2019) (18)
- Comparison of Molecular Multiplex and Singleplex Analysis of IgE to Grass Pollen Allergens in Untreated German Grass Pollen-Allergic Patients. (2015) (18)
- The European Competence Network on Mastocytosis (2004) (17)
- Dilemmas of allergy diagnosis in perioperative anaphylaxis (2014) (17)
- [Reversible increase in photosensitivity to UV-B caused by St. John's wort extract]. (1997) (16)
- IgG4 is Elevated in Eosinophilic Esophagitis but Not in Gastroesophageal Reflux Disease Patients (2020) (16)
- Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseases (2020) (16)
- Tryptase concentration in skin blister fluid from patients with bullous skin conditions (1996) (16)
- [Treatment of acute exacerbated atopic eczema with emollient-antiseptic preparations using the "wet wrap" ("wet pajama") technique]. (1999) (16)
- Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review. (2021) (16)
- Evaluation of the efficiency of enological procedures on lysozyme depletion in wine by an indirect ELISA method. (2014) (16)
- α-Gal-a new clue for anaphylaxis in mastocytosis. (2016) (16)
- Radiotherapy with soft X‐rays in Dupuytren's disease – successful, well‐tolerated and satisfying (2015) (15)
- Papular-purpuric gloves and socks syndrome (2011) (15)
- Cytogenetic and molecular aberrations and worse outcome for male patients in systemic mastocytosis (2021) (14)
- Perioperative drug reactions – practical recommendations for allergy testing and patient management (2018) (14)
- Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis (2021) (14)
- The European Competence Network on Mastocytosis (ECNM). (2004) (13)
- Clinical and serological follow-up of patients with WDEIA (2019) (13)
- Allergy and sensitization to Hymenoptera venoms in unreferred adults with a high risk of sting exposure (2019) (13)
- Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis (2021) (13)
- Successful treatment with infliximab despite positive tuberculosis ELISpot results in a patient with pityriasis rubra pilaris taking prophylactic isoniazid (2011) (13)
- Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest Group (2020) (12)
- Genetic variants associated with T cell–mediated cutaneous adverse drug reactions: A PRISMA‐compliant systematic review—An EAACI position paper (2020) (12)
- Food-induced anaphylaxis and cofactors – data from the anaphylaxis registry (2017) (12)
- Clonal Mast Cell Activation Syndrome with Anaphylaxis to Sulfites (2013) (11)
- Skin manifestations reported in association with COVID‐19 infection (2020) (11)
- A computational model to predict severity of atopic eczema from 30 serum proteins. (2016) (11)
- Management of anaphylaxis due to COVID‐19 vaccines in the elderly (2021) (11)
- Position statement: The need for EU legislation to require disclosure and labelling of the composition of medical devices (2021) (11)
- Global Classification of Mast Cell Activation Disorders An ICD-10-CM-Adjusted Proposal of the ECNM-AIM Consortium. (2022) (10)
- Late elicitation of maculopapular exanthemas to iodinated contrast media after first exposure. (2013) (10)
- [Covid-19 vaccination and risk of anaphylaxis - Recommendations for practical management]. (2021) (10)
- EAACI Biologicals Guidelines—dupilumab for children and adults with moderate‐to‐severe atopic dermatitis (2020) (10)
- Clinical features and management of superficial fibromatoses (2019) (10)
- Fatal anaphylaxis following a hornet sting in a yellow jacket venom-sensitized patient with undetected monoclonal mast cell activation syndrome and without previous history of a systemic sting reaction. (2019) (9)
- Standards and standardization in mastocytosis (2007) (9)
- 654 Positive intracutaneous and oral provocation test in a child with an anaphylactoid reaction to paracetamol (1996) (9)
- Orange-induced skin lesions in patients with atopic eczema: evidence for a non-IgE-mediated mechanism. (2003) (9)
- Pegvaliase: Immunological profile and recommendations for the clinical management of hypersensitivity reactions in patients with phenylketonuria treated with this enzyme substitution therapy. (2019) (9)
- Standards of Genetic Testing in the Diagnosis and Prognostication of Systemic Mastocytosis in 2022: Recommendations of the EU-US Cooperative Group. (2022) (8)
- Management of suspected and confirmed COVID‐19 (SARS‐CoV‐2) vaccine hypersensitivity (2022) (8)
- Mast Cell Activation Syndromes: Collegium Internationale Allergologicum Update 2022 (2022) (8)
- Triage Strategies for Clarifying Reported Betalactam Allergy. (2019) (8)
- "Idiopathic" anaphylaxis caused by carboxymethylcellulose in ice cream. (2020) (8)
- Hymenoptera-induced anaphylaxis: is it a mast cell driven hematological disorder? (2017) (8)
- Teil 1: Klassifikation und Diagnostik der Urtikaria - deutschsprachige Version der internationalen S3-Leitlinie* (2011) (8)
- EAACI anaphylaxis guidelines: systematic review protocol (2020) (8)
- 22 – Mast cells, basophils, and mastocytosis (2008) (7)
- Supportive care of patients with anaphylaxis — options and shortcomings: an assessment on behalf of the working group on anaphylaxis training and education (AGATE), Germany (2016) (7)
- It looks like childhood eczema but is it? (2019) (7)
- Diagnosis and therapy of bee and wasp venom allergy (2012) (7)
- Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GA 2 LEN platform. The (2009) (7)
- Anaphylaxis in Patients with Mastocytosis - a Prospective Study on Prevalence, Severity and Trigger Factors in 121 Patients (2006) (7)
- Allergic myocardial infarction (Kounis syndrome) after cefuroxime with side-chain cross-reactivity. (2018) (7)
- Clinical Impact and Proposed Application of Molecular Markers, Genetic Variants and Cytogenetic Analysis in Mast Cell Neoplasms: Status 2022. (2022) (7)
- Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food—A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paper (2021) (7)
- Standards for practical intravenous rapid drug desensitization & delabeling: A WAO committee statement (2022) (6)
- Position paper Diagnosis of immediate allergic reactions to beta-lactam antibiotics (2003) (6)
- Time for more clinical research on non‐steroidal anti‐inflammatory drug‐induced urticaria/angioedema and anaphylaxis (2013) (6)
- Drug Allergy: Definitions and Phenotypes (2018) (6)
- S3‐Leitlinie Urtikaria. Teil 2: Therapie der Urtikaria – deutschsprachige Adaption der internationalen S3‐Leitlinie (2012) (6)
- Do basophil activation tests help elucidate allergic reactions to the ingredients in COVID‐19 vaccines? (2022) (6)
- Reduced iodinated contrast media dose and injection speed for CT: how much does this decrease the risk of a hypersensitivity reactions? (2020) (6)
- S3‐Leitlinie Urtikaria. Teil 1: Klassifikation und Diagnostik der Urtikaria – deutschsprachige Adaptation der internationalen S3‐Leitlinie (2011) (6)
- EAACI Biologicals Guidelines—Omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12–17 years old (2021) (6)
- [Mast cell activation syndrome]. (2013) (6)
- The basophil activation test differentiates between patients with wheat‐dependent exercise‐induced anaphylaxis and control subjects using gluten and isolated gluten protein types (2021) (6)
- Food anaphylaxis (2009) (5)
- New aspects in allergy education with special emphasis on anaphylaxis (2017) (5)
- Health-related quality of life and influencing factors in adults with non-advanced mastocytosis - a cross-sectional study and qualitative approach. (2021) (5)
- Personalized Management Strategies in Mast Cell Disorders: ECNM-AIM User´s Guide for Daily Clinical Practice. (2022) (5)
- Cutaneous drug hypersensitivity: developments and controversies. (2019) (5)
- Scoring the risk of having systemic mastocytosis in adult patients with mastocytosis in the skin. (2020) (5)
- Extravasation of docetaxel (2012) (4)
- Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis (ECNM). (2021) (4)
- Generalized erythematous macules and plaques associated with flushing, repeated syncope, and refractory anemia. (2002) (4)
- Superficial radiation therapy in peyronie’s disease: An effective and well-tolerated therapy (2018) (4)
- Towards a more precise diagnosis of hypersensitivity to betalactams (2020) (4)
- Suspected penicillin allergy: risk assessment using an algorithm as an antibiotic stewardship project (2020) (4)
- Proposed ECNM-AIM Response Criteria in Advanced Systemic Mastocytosis. (2022) (4)
- Refined Treatment Response Criteria for Indolent Systemic Mastocytosis proposed by the ECNM-AIM Consortium. (2022) (4)
- Gelatin-Containing Vaccines for Varicella, Zoster, Measles, Mumps, and Rubella Induce Basophil Activation in Patients with Alpha-Gal Syndrome (2021) (4)
- Patients with questionable penicillin (beta-lactam) allergy: Causes and solutions (2022) (4)
- Standards of Pathology in the Diagnosis of Systemic Mastocytosis: Recommendations of the EU-US Cooperative Group. (2022) (4)
- Variability of eliciting thresholds in PEG allergy limits prediction of tolerance to PEG-containing mRNA COVID vaccines (2022) (4)
- [Triggers of exanthematous drug eruptions: Stop intake, treat through or desensitization?] (2017) (4)
- Negative oral provocation test with porcine pancreatic enzyme plus cofactors despite confirmed α-Gal syndrome. (2020) (4)
- Exposure of grass pollen to volatile organic compounds enhances skin prick test reactivity. (2008) (4)
- Detection of drug-specific immunoglobulin E (IgE) and acute mediator release for the diagnosis of immediate drug hypersensitivity reactions. (2021) (4)
- Mast Cell Leukemia: Clinical and Molecular Features and Survival Outcomes of Patients in the ECNM Registry. (2022) (4)
- [Recurring episodes of fever with oral aphthae, lymph node swelling and joint symptoms in a 9-year-old boy. Diagnosis: PFAPA syndrome (Marshall syndrome)]. (2003) (3)
- Allergy to Radiocontrast Dye. (2022) (3)
- Educational programmes in food allergy. (2015) (3)
- Real‐life evaluation of molecular multiplex IgE test methods in the diagnosis of pollen associated food allergy (2022) (3)
- Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis with Symptoms Inadequately Controlled with Standard Therapy (2019) (3)
- 703 Skin test reactivity in patients with latex allergy (2000) (3)
- Correction to: Guideline for the diagnosis of drug hypersensitivity reactions (2018) (3)
- Diagnosis and Prevention of Hypersensitivity Reactions to Iodinated Contrast Media (2022) (3)
- [Emergency treatment and management of anaphylaxis]. (2013) (3)
- Rare Ingestive Food Allergy to Mushroom Boletus badius. (2017) (3)
- Tolerance to SARS-CoV-2 mRNA vaccination in a patient with challenge-confirmed PEG 2000 allergy. (2022) (2)
- Low risk of contrast media induced hypersensitivity reactions in all subtypes of systemic mastocytosis. (2021) (2)
- Predominant patterns of β-lactam hypersensitivity in a single German Allergy Center: exanthem induced by aminopenicillins, anaphylaxis by cephalosporins (2020) (2)
- Messages for patients and relatives from the 2021 update of the guideline on acute therapy and management of anaphylaxis (2021) (2)
- A high-troughput screening assay for detection of auto-IgE (2012) (2)
- Reply to: “Include desensitization to radiocontrast media in the diagnostic algorithm” (2021) (2)
- Advances in our understanding of drug hypersensitivity (2013) (2)
- Research needs in allergy (2012) (2)
- Serum IgE against galactose-alpha-1,3-galactose is common in Laotian patients with snakebite envenoming but not the major trigger for early anaphylactic reactions to antivenom (2020) (2)
- Selection and Efficacy of Cytoreductive Agents in Patients with Mastocytosis Included in the Registry of the European Competence Network on Mastocytosis (ECNM) (2017) (2)
- A Challenge for Allergologist: Application of Allergy Diagnostic Methods in Mast Cell Disorders (2021) (2)
- REDALL (Reduced allergenicity of processed foods) - allergen-reduced foods as alternative to avoidance in food allergy? (2008) (2)
- [Radiographic contrast media hypersensitivity. New understanding of pathophysiology with implications for patient management]. (2005) (2)
- Efficacy and safety of dupilumab for moderate-to-severe atopic dermatitis: a systematic review for the EAACI Biologicals Guidelines (2020) (2)
- Mast Cell Diseases in Practice and Research: Issues and Perspectives Raised by Patients and Their Recommendations to the Scientific Community and Beyond. (2022) (2)
- A shortened docetaxel desensitization protocol for use in special cases (2012) (2)
- Severe photoallergy to systemic dronedarοne (Multaq). (2020) (2)
- Basophil Activation to Gluten and Non-Gluten Proteins in Wheat-Dependent Exercise-Induced Anaphylaxis (2022) (2)
- Is neutrophilic desquamative erythroderma a form of acute generalized exanthematous pustulosis? (2018) (1)
- Guideline (S2k) on acute therapy and management of anaphylaxis - 2021 Update (2021) (1)
- Delayed bullous pressure urticaria: the puzzling role of eosinophils (2018) (1)
- PEG allergy — A COVID-19 pandemic-made problem? A German perspective (2022) (1)
- Safety of rush hymenoptera venom immunotherapy (2004) (1)
- Prognostic Factors and Survival Prediction in 1,088 Patients with Mastocytosis Collected in the Registry of the European Competence Network on Mastocytosis (ECNM Registry) (2016) (1)
- Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis (2002) (1)
- Sublingual immunotherapy reduces reaction threshold in three patients with wheat‐dependent exercise‐induced anaphylaxis (2021) (1)
- 2 LEN guideline : aspirin provocation tests for diagnosis of aspirin hypersensitivity (2007) (1)
- Increasing the COVID-19 immunization rate through allergy testing. (2023) (1)
- Reduced skin reactivity to vasoconstrictor and vasodilator substances in atopic eczema. (2013) (1)
- Anaphylaxis in Mastocytosis (2019) (1)
- Allergological diagnostics of hypersensitivity reactions to drugs (2008) (1)
- [Anaphylaxis - how to act fast and sustainable]. (2019) (1)
- Trends in the Prevalence of Methylchloroisothiazolinone/Methylisothiazolinone Contact Allergy in North America and Europe. (2023) (1)
- Systemic mastocytosis with generalised skin involvement (2017) (1)
- Psoriasiform Dermatitis During Infliximab Therapy for Ulcerative Colitis. (2020) (1)
- Promising Use Of The New Biologics In The Management Of Drug-Induced Hypersensitivity Reactions: Preliminary Approaches. (2020) (1)
- [Skin care for children with atopic eczema]. (1997) (1)
- Cutaneous reactions following COVID‐19 vaccination assessed by dermatologists: a single‐institutional study in Germany (2023) (1)
- Wheat-Dependent, Exercise-Induced Anaphylaxis Can Be Elicited Without Exercise (And With Other Co-factors) (2016) (1)
- Hypersensitivity reactions to iodinated contrast media-our experience (2009) (1)
- [Benign course of diffuse cutaneous mastocytosis with massive blisters]. (2015) (1)
- Intravenous provocation test with contrast media in a patient with symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) after administration of Iomeprol (2009) (1)
- [Treatment of atopic eczema in childhood]. (1997) (1)
- Demodicidosis associated with psoriasis therapy – two case reports (2013) (1)
- When and how to evaluate for immediate type food allergy in children with atopic dermatitis. (2021) (1)
- Reply to: “Include desensitization to radio contrast media in the diagnostic algorithm” (2020) (0)
- Diagnostic value of mast cell mediators in anaphylaxis (2005) (0)
- Management and outcome of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity. (2021) (0)
- Tolerance of wines fined with allergenic proteins in allergic individuals-double-blind, placebo controlled food challenge study (2008) (0)
- Legends of Allergy and Immunology—Dean D. Metcalfe (2023) (0)
- [Immediate drug hypersensitivity. Epidemiology, clinical features, triggers and management]. (2014) (0)
- Successful usage of a chatbot to standardize and automate history taking in Hymenoptera venom allergy. (2023) (0)
- Rush-desensitization in docetaxel hypersensitivity - case report and review of the literature (2012) (0)
- Impact of pollen associated lipid mediators (PALMs) from grass pollen on human mast cells (2007) (0)
- [Pediatric dermatotherapy]. (2003) (0)
- der Mastozytose New Therapeutic Developments for Mastocytosis (2009) (0)
- Cytochromes P450 modulate adjuvant effects of the air pollutant phenanthrene in the IgE-dependent immune response (2004) (0)
- Subject Index Vol. 143, 2007 (2007) (0)
- COVID-19-vaccination in patients receiving allergen immunotherapy (AIT) or biologics - EAACI recommendations (2021) (0)
- [Systemic therapy in the treatment concept of atopic eczema. Reliable treatment methods and experimental developments]. (1999) (0)
- Wheat‐dependent exercise‐induced anaphylaxis caused by percutaneous sensitisation to hydrolysed wheat protein in cosmetics (2022) (0)
- Anaphylaxis: classification and clinical symptoms (2014) (0)
- S3 Guideline Urticaria. Part 1: Classification and diagnosis of urticaria – German‐language adaptation of the international S3 Guideline (2023) (0)
- Training Approach to Anaphylaxis (2011) (0)
- [Allergic emergencies]. (2018) (0)
- Mastocytosis - diagnosis and classification (2009) (0)
- Contents Vol. 143, 2007 (2007) (0)
- Immediate-Type Allergy: Rhinoconjunctivitis, Asthma, Anaphylaxis (2020) (0)
- 722 Postmortem diagnosis of an anaphylactoid reaction due to non-ionic radiocontrast media by serum tryptase analysis: A case report (1996) (0)
- 420 Cytochrome P450s are deactivators of the aryl hydrocarbon receptor in human immune cells (2016) (0)
- Validation of dermatopathological criteria to diagnose cutaneous lesions of mastocytosis: importance of KIT D816V mutation analysis (2022) (0)
- SARS-CoV-2 and allergy – what have we learned after two and a half years? (2023) (0)
- History and classi¢cation of anaphylaxis (2004) (0)
- XXIII Congress of the EAACI, Amsterdam 2004 (2004) (0)
- Proposed International Prognostic Scoring System for Mastocytosis (IPSM) (2019) (0)
- Evaluation of Allergologic Tests in Exanthematous Drug Eruptions after Application of Mesna (2003) (0)
- Emergency management of anaphylaxis (2010) (0)
- Endogenous biosensors in allergy: cytochrome P450s and the aryl hydrocarbon receptor (2013) (0)
- Anaphylaxis: subjective symptom reports of patients with a special focus on “near-death” experiences (2021) (0)
- Immunologie I (2011) (0)
- Plantar Erythrodysesthesia Caused by Antiretroviral Treatment: A Case Report and Review of the Literature (2013) (0)
- Issue Information (2021) (0)
- A clinical reaction can be elicited without cofactors in Wheat dependent exercise induced anaphylaxis (2015) (0)
- Unsatisfactory agreement using current classification of maculopapular cutaneous mastocytosis (2021) (0)
- [Generalized skin change in a newborn infant: infectious, genetic or autoimmune cause? Epidermolytic ichthyosis]. (2013) (0)
- S3 Guideline Urticaria. Part 2: Treatment of urticaria – German‐language adaptation of the international S3 guideline (2023) (0)
- Issue Information (2021) (0)
- Diagnosing and Managing Patients with Reactions to Radiocontrast Media (2021) (0)
- Post-acute phase and sequelae management of epidermal necrolysis: an international, multidisciplinary DELPHI-based consensus (2023) (0)
- Metamizole‐induced reactions as a paradigm of drug hypersensitivity: Non‐allergic reactions, anaphylaxis, and delayed‐type allergy (2020) (0)
- A rapid impedimetric procedure for quantification of staphylococcal skin colonization in atopic eczema (1998) (0)
- Sensitisation and delayed manifestation of allergic exanthemas to iodinated contrast media upon first single dose exposure (2012) (0)
- [Removing the allergen, adrenaline, cortisone. First aid in anaphylaxis]. (2001) (0)
- Key Words (2004) (0)
- CMR 2005: 11.06: European multicenter study on contrast media hypersensitivity (2006) (0)
- 39th Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF) (2012) (0)
- Effect of Various Treatments and Filtration Methods on Eliminating Residues of Casein-based Fining Agents from Wine (2015) (0)
- Atopic eczema and allergic rhinitis show a dichotomic pattern of IgE-autoreactivity against skin, lung and intestinal epithelium (2012) (0)
- [Allergy--triggers of life-threatening and fatal anaphylaxis]. (2006) (0)
- Periorbital papules and erythematous‐brownish plaques on the neck and axilla (2015) (0)
- Adverse Cutaneous Drug Eruptions-ReadingSample (2015) (0)
- Thank you to reviewers (2016) (0)
- Explorer Research needs in allergy (2017) (0)
- Antibiotic hypersensitivity in cystic fibrosis – Low frequency of anaphylaxis over 16 000 courses (2022) (0)
- [Mixed tumor of the skin]. (2011) (0)
- Issue Information (2021) (0)
- Severe secondary osteoporosis in a patient with systemic mastocytosis stabilized by therapy with low-dose pegylated interferon alpha (2008) (0)
- [Induction of penicillin tolerance during pregnancy : Allergological opinion on the recommendation of the current Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002)]. (2021) (0)
- Induction of penicillin tolerance during pregnancy: Allergological opinion on the recommendation of the current AWMF Guidelines on Diagnosis and Treatment of Syphilis (AWMF Registry No. 059-002) (2021) (0)
- 15. Mainzer Allergie-Workshop 2003 (2003) (0)
- Dihydroxyacetone (Autohélios®): a powerful therapeutical option in vitiligo (1998) (0)
- Prognostic Impact of Organomegaly in Mastocytosis: An Analysis of the European Competence Network on Mastocytosis. (2022) (0)
- Therapy of urticaria: German language version of the international S3-guideline (2012) (0)
- Skin Immune System: T cells (2019) (0)
- MR-based trabecular bone microstructure is not altered in subjects with indolent systemic mastocytosis. (2015) (0)
- Anaphylaxis to bay boletus. (2014) (0)
- The Tryptase Test Clinical Use in Dermatology and Allergy (2017) (0)
- UvA-DARE ( Digital Academic Repository ) Reducing the Risk of Anaphylaxis During Anesthesia : 2011 Updated Guidelines for Clinical Practice (2011) (0)
- Adverse Reactions and Their Pathophysiology and Management (1999) (0)
- Efficacy and safety of treatment with omalizumab for chronic spontaneous urticaria- a systematic review for the EAACI Biologicals Guidelines (2020) (0)
- Mischtumor der Haut (2010) (0)
- Management of anaphylaxis - new developments from guidelines. (2014) (0)
- European Competence Network on Mastocytosis (ECNM): 20-Year Jubilee, Updates, and Future Perspectives. (2023) (0)
- Transplantation of a fixed Drug Reaction - Insights into the resident Immune System of the Skin (2015) (0)
- Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review et al . Genetic variants associated with drugs-induced immediate hypersensitivity reactions: a PRISMA-compliant systematic review. Allergy 2016, (2022) (0)
- Detection of auto-IgE in pediatric atopic eczema indicates autosensitization as an early immunological event. (177.12) (2012) (0)
- Basic Principles in Allergology and Hypersensitivity Reactions (2020) (0)
- Does Wine Containing Processing Aids Present a Risk for Allergic Consumers? - Results of a Double-blind, Placebo-controlled Food Challenge. (2009) (0)
- A new way forward? Examining the potential of quantitative analysis of IgE datasets (2022) (0)
- Comprehensive characterization of central BCL-2 family members in aberrant eosinophils and their impact on therapeutic strategies (2021) (0)
- Wheat-dependent exercise-induced Anaphylaxis (WDEIA) – Fehldiagnosen vermeiden (2023) (0)
- Skin Changes Revealing a Disorder of Lipid Metabolism. (2018) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Knut Brockow?
Knut Brockow is affiliated with the following schools:
